Prospective, phenotype-driven selection of critically ill neonates for rapid exome sequencing is associated with high diagnostic yield

Abstract

Purpose

To investigate the impact of rapid-turnaround exome sequencing in critically ill neonates using phenotype-based subject selection criteria.

Methods

Intensive care unit babies aged <6 months with hypotonia, seizures, a complex metabolic phenotype, and/or multiple congenital malformations were prospectively enrolled for rapid (<7 day) trio-based exome sequencing. Genomic variants relevant to the presenting phenotype were returned to the medical team.

Results

A genetic diagnosis was attained in 29 of 50 (58%) sequenced cases. Twenty-seven (54%) patients received a molecular diagnosis involving known disease genes; two additional cases (4%) were solved with pathogenic variants found in novel disease genes. In 24 of the solved cases, diagnosis had impact on patient management and/or family members. Management changes included shift to palliative care, medication changes, involvement of additional specialties, and the consideration of new experimental therapies.

Conclusion

Phenotype-based patient selection is effective at identifying critically ill neonates with a high likelihood of receiving a molecular diagnosis via rapid-turnaround exome sequencing, leading to faster and more accurate diagnoses, reducing unnecessary testing and procedures, and informing medical care.

Access options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

Fig. 1

References

  1. 1.

    Yoon PW, Olney RS, Khoury MJ, Sappenfield WM, Chavez GF, Taylor D. Contribution of birth defects and genetic diseases to pediatric hospitalizations. Arch Pediatr Adolesc Med. 1997;151:1096.

    CAS  Article  Google Scholar 

  2. 2.

    Wojcik MH, Schwartz TS, Yamin I, et al. Genetic disorders and mortality in infancy and early childhood: delayed diagnoses and missed opportunities. Genet Med. 2018;20:1396–1404.

    Article  Google Scholar 

  3. 3.

    Iglesias A, Anyane-Yeboa K, Wynn J, et al. The usefulness of whole-exome sequencing in routine clinical practice. Genet Med. 2014;16:922–931.

    Article  Google Scholar 

  4. 4.

    Daoud H, Luco SM, Li R, et al. Next-generation sequencing for diagnosis of rare diseases in the neonatal intensive care unit. Can Med Assoc J. 2016;188:E254–E260.

    Article  Google Scholar 

  5. 5.

    French CE, Delon I, Dolling H, et al. Whole genome sequencing reveals that genetic conditions are frequent in intensively ill children. Intensive Care Med. 2019;45:627–636.

    CAS  Article  Google Scholar 

  6. 6.

    Stark Z, Schofield D, Alam K, et al. Prospective comparison of the cost-effectiveness of clinical whole-exome sequencing with that of usual care overwhelmingly supports early use and reimbursement. Genet Med. 2017;19:867–874.

    Article  Google Scholar 

  7. 7.

    Meng L, Pammi M, Saronwala A, et al. Use of exome sequencing for infants in intensive care units. JAMA Pediatr. 2017;171:e173438.

    Article  Google Scholar 

  8. 8.

    Willig LK, Petrikin JE, Smith LD, et al. Whole-genome sequencing for identification of Mendelian disorders in critically ill infants: a retrospective analysis of diagnostic and clinical findings. Lancet Respir Med. 2015;3:377–387.

    CAS  Article  Google Scholar 

  9. 9.

    van Diemen CC, Kerstjens-Frederikse WS, Bergman KA, et al. Rapid targeted genomics in critically ill newborns. Pediatrics. 2017;140:e20162854.

    Article  Google Scholar 

  10. 10.

    Farnaes L, Hildreth A, Sweeney NM, et al. Rapid whole-genome sequencing decreases infant morbidity and cost of hospitalization. NPJ Genomic Med. 2018;3:10.

    Article  Google Scholar 

  11. 11.

    Petrikin JE, Willig LK, Smith LD, Kingsmore SF. Rapid whole genome sequencing and precision neonatology. Semin Perinatol. 2015;39:623–631.

    Article  Google Scholar 

  12. 12.

    Elliott AM, du Souich C, Lehman A, et al. RAPIDOMICS: rapid genome-wide sequencing in a neonatal intensive care unit—successes and challenges. Eur J Pediatr. 2019;178:1207–1218.

    CAS  Article  Google Scholar 

  13. 13.

    Mestek-Boukhibar L, Clement E, Jones WD, et al. Rapid Paediatric Sequencing (RaPS): comprehensive real-life workflow for rapid diagnosis of critically ill children. J Med Genet. 2018;55:721–728.

    CAS  Article  Google Scholar 

  14. 14.

    Ceyhan-Birsoy O, Ceyhan-Birsoy O, Murry JB, et al. Interpretation of genomic sequencing results in healthy and ill newborns: results from the BabySeq Project. Am J Hum Genet. 2019;104:76–93.

    CAS  Article  Google Scholar 

  15. 15.

    Retterer K, Juusola J, Cho MT, et al. Clinical application of whole-exome sequencing across clinical indications. Genet Med. 2016;18:696–704.

    CAS  Article  Google Scholar 

  16. 16.

    Kalia SS, Adelman K, Bale SJ, et al. Recommendations for reporting of secondary findings in clinical exome and genome sequencing, 2016 update (ACMG SF v2.0): a policy statement of the American College of Medical Genetics and Genomics. Genet Med. 2017;19:249–255.

    Article  Google Scholar 

  17. 17.

    Sobreira N, Schiettecatte F, Valle D, Hamosh A. GeneMatcher: a matching tool for connecting investigators with an interest in the same gene. Hum Mutat. 2015;36:928–930.

    Article  Google Scholar 

  18. 18.

    Kanca O, Andrews JC, Lee P, et al. De novo variants in WDR37 are associated with epilepsy, colobomas, dysmorphism, developmental delay, intellectual disability, and cerebellar hypoplasia. Am J Hum Genet. 2019;105:413–424.

    CAS  Article  Google Scholar 

  19. 19.

    Alcantara D, Elmslie F, Tetreault M, et al. SHORT syndrome due to a novel de novo mutation in PRKCE (Protein Kinase Cɛ) impairing TORC2-dependent AKT activation. Hum Mol Genet. 2017;26:3713–3721.

    CAS  Article  Google Scholar 

  20. 20.

    Marangi G, Di Giacomo MC, Lattante S, et al. A novel truncating variant within exon 7 of KAT6B associated with features of both Say-Barber-Biesecker-Young-Simpson syndrome and genitopatellar syndrome: further evidence of a continuum in the clinical spectrum of KAT6B-related disorders. Am J Med Genet Part A. 2018;176:455–459.

    CAS  Article  Google Scholar 

  21. 21.

    Moran J, G. Sanderson K, Maynes J, et al. IFT80 mutations cause a novel complex ciliopathy phenotype with retinal degeneration. Clin Genet. 2018;94:368–372.

    CAS  Article  Google Scholar 

  22. 22.

    Bizaoui V, Huber C, Kohaut E, et al. Mutations in IFT80 cause SRPS type IV. Report of two families and review. Am J Med Genet Part A. 2019;179:639–644.

    Article  Google Scholar 

  23. 23.

    Dilena R, Striano P, Gennaro E, et al. Efficacy of sodium channel blockers in SCN2A early infantile epileptic encephalopathy. Brain Dev. 2017;39:345–348.

    Article  Google Scholar 

  24. 24.

    Beggs AH, Byrne BJ, De Chastonay S, et al. A multicenter, retrospective medical record review of X‐linked myotubular myopathy: the recensus study. Muscle Nerve. 2018;57:550–560.

    Article  Google Scholar 

  25. 25.

    El-Hattab AW, Craigen WJ, Scaglia F. Mitochondrial DNA maintenance defects. Biochim Biophys Acta Mol Basis Dis. 2017;1863:1539–1555.

    CAS  Article  Google Scholar 

  26. 26.

    Maiese DR, Keehn A, Lyon M, Flannery D, Watson M. Current conditions in medical genetics practice. Genet Med. 2019;21:1874–1877.

    Article  Google Scholar 

  27. 27.

    Genetti CA, Schwartz TS, Robinson JO, et al. Parental interest in genomic sequencing of newborns: enrollment experience from the BabySeq Project. Genet Med. 2019;21:622–630.

    Article  Google Scholar 

  28. 28.

    Loupatty FJ, Clayton PT, Ruiter JPN, et al. Mutations in the gene encoding 3-hydroxyisobutyryl-CoA hydrolase results in progressive infantile neurodegeneration. Am J Hum Genet. 2007;80:195–199.

    CAS  Article  Google Scholar 

  29. 29.

    Miller NA, Farrow EG, Gibson M, et al. A 26-hour system of highly sensitive whole genome sequencing for emergency management of genetic diseases. Genome Med. 2015;7:100.

    Article  Google Scholar 

  30. 30.

    Petrikin JE, Cakici JA, Clark MM, et al. The NSIGHT1-randomized controlled trial: rapid whole-genome sequencing for accelerated etiologic diagnosis in critically ill infants. NPJ Genomic Med. 2018;3:6.

    Article  Google Scholar 

  31. 31.

    Saunders CJ, Miller NA, Soden SE, et al. Rapid whole-genome sequencing for genetic disease diagnosis in neonatal intensive care units. Sci Transl Med. 2012;4:154ra135.

    Article  Google Scholar 

  32. 32.

    Gonorazky HD, Naumenko S, Ramani AK, et al. Expanding the boundaries of RNA sequencing as a diagnostic tool for rare Mendelian disease. Am J Hum Genet. 2019;104:466–483.

    CAS  Article  Google Scholar 

  33. 33.

    Schmitz-Abe K, Li Q, Rosen SM, et al. Unique bioinformatic approach and comprehensive reanalysis improve diagnostic yield of clinical exomes. Eur J Hum Genet. 2019 Apr 12; [Epub ahead of print].

  34. 34.

    Manzini MC, Tambunan DE, Hill RS, et al. Exome sequencing and functional validation in zebrafish identify GTDC2 mutations as a cause of Walker-Warburg syndrome. Am J Hum Genet. 2012;91:541–547.

    CAS  Article  Google Scholar 

  35. 35.

    Valente EM, Brancati F, Silhavy JL, et al. AHI1 gene mutations cause specific forms of Joubert syndrome–related disorders. Ann Neurol. 2006;59:1527–34.

    Article  Google Scholar 

  36. 36.

    Schuurs-Hoeijmakers JHM, Landsverk ML, Foulds N, et al. Clinical delineation of the PACS1 -related syndrome—report on 19 patients. Am J Med Genet Part A. 2016;170:670–675.

    CAS  Article  Google Scholar 

  37. 37.

    Liu N, Zhuo Z-H, Wang H-L, et al. Prenatal diagnosis based on HPRT1 gene mutation in a Lesch–Nyhan family. J Obstet Gynaecol. 2015;35:490–493.

    CAS  Article  Google Scholar 

Download references

Acknowledgements

The research team thanks all clinical teams involved for their help, as well as the patients and their families. This work was supported in part by a sponsored research agreement between GeneDx and Boston Children’s Hospital; the National Institutes of Health under award numbers U19HD077671, U54HD090255, R01AR068429, and R01HD075802; the William F. Milton Fund; and the resources of The Manton Center for Orphan Disease Research Gene Discovery Core. C.S.G. was partly supported by a William Randolph Hearst Fellowship. M.H.W. was supported by T32 GM 7748-40.

Author information

Affiliations

Authors

Corresponding authors

Correspondence to Pankaj B. Agrawal MD, MMSc or Timothy W. Yu MD, PhD.

Ethics declarations

Disclosure

Rapid exome sequencing for this study was performed by GeneDx, a commercial genetic diagnostic company. Authors D.C., S.Y., and J.J. are employed by GeneDx. The other authors declare no conflicts of interest.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary information

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Gubbels, C.S., VanNoy, G.E., Madden, J.A. et al. Prospective, phenotype-driven selection of critically ill neonates for rapid exome sequencing is associated with high diagnostic yield. Genet Med 22, 736–744 (2020). https://doi.org/10.1038/s41436-019-0708-6

Download citation

Keywords

  • exome sequencing
  • neonates
  • intensive care unit

Further reading

Search

Quick links